Two Sigma Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $231M | Buy |
6,286,501
+5,943,310
| +1,732% | +$282M | 0.19% | 118 |
|
|
2025
Q4 | $17.5M | Sell |
343,191
-1,348,335
| -80% | -$68.9M | 0.02% | 791 |
|
|
2025
Q3 | $93.9M | Sell |
1,691,526
-525,424
| -24% | -$30.8M | 0.14% | 201 |
|
|
2025
Q2 | $153M | Sell |
2,216,950
-930,979
| -30% | -$63.3M | 0.27% | 89 |
|
|
2025
Q1 | $219M | Buy |
3,147,929
+1,303,506
| +71% | +$108M | 0.47% | 35 |
|
|
2024
Q4 | $159M | Buy |
+1,844,423
| New | +$199M | 0.35% | 60 |
|
|
2024
Q1 | – | Sell |
-21,600
| Closed | -$2.23M | – | 3269 |
|
|
2023
Q4 | $2.23M | Sell |
21,600
-30
| -0.1% | -$2.97K | 0.01% | 1450 |
|
|
2023
Q3 | $1.97M | Sell |
21,630
-641,704
| -97% | -$56.5M | 0.01% | 1395 |
|
|
2023
Q2 | $53.7M | Buy |
663,334
+602,682
| +994% | +$49.2M | 0.13% | 199 |
|
|
2023
Q1 | $4.83M | Buy |
60,652
+42,652
| +237% | +$3.02M | 0.01% | 933 |
|
|
2022
Q4 | $1.22M | Buy |
+18,000
| New | +$1.06M | ﹤0.01% | 1599 |
|
|
2022
Q3 | – | Sell |
-256,334
| Closed | -$14.3M | – | 2708 |
|
|
2022
Q2 | $14.3M | Buy |
256,334
+38,768
| +18% | +$2.15M | 0.05% | 408 |
|
|
2022
Q1 | $12.1M | Sell |
217,566
-453,564
| -68% | -$23.3M | 0.04% | 546 |
|
|
2021
Q4 | $37.6M | Sell |
671,130
-879,068
| -57% | -$47.6M | 0.08% | 301 |
|
|
2021
Q3 | $74.4M | Buy |
1,550,198
+630,348
| +69% | +$30.5M | 0.17% | 145 |
|
|
2021
Q2 | $38.5M | Buy |
919,850
+19,772
| +2% | +$766K | 0.09% | 270 |
|
|
2021
Q1 | $30.3M | Sell |
900,078
-203,952
| -18% | -$7.26M | 0.08% | 293 |
|
|
2020
Q4 | $38.6M | Buy |
1,104,030
+144,090
| +15% | +$4.98M | 0.11% | 208 |
|
|
2020
Q3 | $33.3M | Sell |
959,940
-407,050
| -30% | -$13.6M | 0.12% | 179 |
|
|
2020
Q2 | $44.8M | Buy |
1,366,990
+750,002
| +122% | +$23.9M | 0.22% | 89 |
|
|
2020
Q1 | $18.6M | Sell |
616,988
-327,532
| -35% | -$9.75M | 0.15% | 137 |
|
|
2019
Q4 | $27.3M | Buy |
944,520
+93,140
| +11% | +$2.58M | 0.08% | 284 |
|
|
2019
Q3 | $22M | Buy |
851,380
+621,826
| +271% | +$15.7M | 0.07% | 327 |
|
|
2019
Q2 | $5.86M | Sell |
229,554
-441,734
| -66% | -$10.9M | 0.02% | 822 |
|
|
2019
Q1 | $17.6M | Sell |
671,288
-641,750
| -49% | -$15.8M | 0.06% | 441 |
|
|
2018
Q4 | $30.2M | Buy |
1,313,038
+7,416
| +0.6% | +$165K | 0.12% | 229 |
|
|
2018
Q3 | $30.8M | Buy |
1,305,622
+1,116,460
| +590% | +$27.2M | 0.08% | 315 |
|
|
2018
Q2 | $4.36M | Buy |
+189,162
| New | +$4.5M | 0.01% | 1092 |
|
|
2017
Q2 | – | Sell |
-1,601,944
| Closed | -$27.5M | – | 3188 |
|
|
2017
Q1 | $27.5M | Buy |
1,601,944
+199,766
| +14% | +$3.48M | 0.09% | 291 |
|
|
2016
Q4 | $25.1M | Buy |
1,402,178
+568,322
| +68% | +$10.3M | 0.1% | 245 |
|
|
2016
Q3 | $17.3M | Buy |
833,856
+816,100
| +4,596% | +$20.2M | 0.06% | 353 |
|
|
2016
Q2 | $477K | Buy |
+17,756
| New | +$487K | ﹤0.01% | 2283 |
|
|
2015
Q3 | – | Sell |
-96,014
| Closed | -$2.63M | – | 2561 |
|
|
2015
Q2 | $2.63M | Buy |
+96,014
| New | +$2.7M | 0.01% | 1044 |
|
|
2015
Q1 | – | Sell |
-251,342
| Closed | -$5.32M | – | 2783 |
|
|
2014
Q4 | $5.32M | Buy |
+251,342
| New | +$5.61M | 0.03% | 625 |
|
|
2014
Q2 | – | Sell |
-93,962
| Closed | -$2.15M | – | 2293 |
|
|
2014
Q1 | $2.15M | Buy |
93,962
+53,212
| +131% | +$1.13M | 0.01% | 915 |
|
|
2013
Q4 | $753K | Sell |
40,750
-595,460
| -94% | -$10.4M | ﹤0.01% | 1464 |
|
|
2013
Q3 | $10.8M | Buy |
636,210
+605,460
| +1,969% | +$10.2M | 0.07% | 340 |
|
|
2013
Q2 | $477K | Buy |
+30,750
| New | +$512K | ﹤0.01% | 1436 |
|
Other funds holding NVO
DAM
F
Two Sigma Investments's NVO Position: Q1 2026 in Review
Two Sigma Investments increased its Novo Nordisk (NVO) stake by 1,732% in Q1 2026, buying an estimated $282M and bringing the position to 6,286,501 shares worth $231M. The position accounts for 0.19% of the portfolio, ranked #118.
Two Sigma Investments first reported a position in NVO in Q2 2013 and has held it in 38 quarters since. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Two Sigma Investments held 6,286,501 shares of Novo Nordisk worth $231M as of Q1 2026.
- Two Sigma Investments bought 5,943,310 Novo Nordisk shares in Q1 2026, an estimated $282M.
- Novo Nordisk made up 0.19% of Two Sigma Investments's portfolio in Q1 2026, its #118 holding.
- Two Sigma Investments first reported a position in Novo Nordisk in Q2 2013 and has held it in 38 quarters since.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.